INVO Fertility (IVF) FCF Margin Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17,826.00 |
| Jun 30, 2025 | 37,509.00 |
| Mar 31, 2025 | 12,441.00 |
| Dec 31, 2024 | 19,338.00 |
| Sep 30, 2024 | 14,147.00 |
| Jun 30, 2024 | -2,151.00 |
| Mar 31, 2024 | -162,432.00 |
| Dec 31, 2023 | 14,009.00 |
| Sep 30, 2023 | -4,535.00 |
| Jun 30, 2023 | -32,804.00 |
| Mar 31, 2023 | -29,413.00 |
| Dec 31, 2022 | -33,701.00 |
| Sep 30, 2022 | -66,130.00 |
| Jun 30, 2022 | -125,654.00 |
| Mar 31, 2022 | -106,571.00 |
| Dec 31, 2021 | 107,705.00 |
| Sep 30, 2021 | -41,568.00 |
| Jun 30, 2021 | 126,791.00 |
| Mar 31, 2021 | 12,577.00 |
| Sep 30, 2020 | 71,747.00 |
| Jun 30, 2020 | -38,040.00 |
| Mar 31, 2020 | 18,654.00 |
| Sep 30, 2019 | -13,766.00 |
| Jun 30, 2019 | -12,360.00 |
| Mar 31, 2019 | 171,598.00 |
| Dec 31, 2018 | -9,988.00 |
| Sep 30, 2018 | 319,722.00 |
| Jun 30, 2018 | 17,746.00 |
| Mar 31, 2018 | 23,307.00 |
| Dec 31, 2017 | 6,456.00 |
| Sep 30, 2017 | 47,768.00 |
| Jun 30, 2017 | -3,137.00 |
| Mar 31, 2017 | -22,013.00 |
| Dec 31, 2016 | -234,128.00 |
| Sep 30, 2016 | 13,300.00 |